Emergent BioSolutions in ‘early innings’ of shift away from Covid-19 vaccine work


Emergent had positioned itself as a contract partner to develop and manufacture vaccines through the Covid crisis, but had a tough year of it.

Previous PNC CEO Bill Demchak: 'Astounding' growth after BBVA acquisition, but a recession could be on the horizon
Next OP health care staffing firm Krucial makes switch from for-profit business to nonprofit